Avani Kanubaddi

2021

In 2021, Avani Kanubaddi earned a total compensation of $4.2M as President and Chief Operating Officer at Enveric Biosciences, a 6,961% increase compared to previous year.

Compensation breakdown

Bonus$144,570
Salary$302,500
Stock Awards$3,789,523
Total$4,236,593

Kanubaddi received $3.8M in stock awards, accounting for 89% of the total pay in 2021.

Kanubaddi also received $144.6K in bonus and $302.5K in salary.

Rankings

In 2021, Avani Kanubaddi's compensation ranked 3,142nd out of 12,406 executives tracked by ExecPay. In other words, Kanubaddi earned more than 74.7% of executives.

ClassificationRankingPercentile
All
3,142
out of 12,406
75th
Division
Manufacturing
1,266
out of 5,492
77th
Major group
Chemicals And Allied Products
515
out of 2,368
78th
Industry group
Drugs
456
out of 2,089
78th
Industry
Pharmaceutical Preparations
314
out of 1,536
80th
Source: SEC filing on September 23, 2022.

Kanubaddi's colleagues

We found four more compensation records of executives who worked with Avani Kanubaddi at Enveric Biosciences in 2021.

2021

David Johnson

Enveric Biosciences

Chairman

2021

Joseph Tucker

Enveric Biosciences

Chief Executive Officer

2021

Robert Wilkins

Enveric Biosciences

Chief Medical Officer

2021

Peter Facchini

Enveric Biosciences

Chief Innovation Officer

News

You may also like